Skip to main content
. Author manuscript; available in PMC: 2011 May 3.
Published in final edited form as: Clin Cancer Res. 2008 Jun 1;14(11):3327–3337. doi: 10.1158/1078-0432.CCR-07-4495

Table 3. Immunohistochemical evaluation of HMGA2 in thyroid tumors.

Total HMGA2 positive HMGA2 negative*

High Moderate Low§
Tissue array samples 87
 Normal thyroid 19 2 17
 Follicular adenoma 14 1 13
 Lymphocytic thyroiditis nodule 11 6 5
 Follicular carcinoma 14 3 2 5 4
 Follicular variant of papillary thyroid carcinoma 9 4 2 1 2
 Papillary thyroid carcinoma 20 7 7 4 2
Nonarrayed samples 38
 Follicular adenoma 11 2 9
 Adenomatoid nodule 10 1 1 8
 Follicular variant of papillary thyroid carcinoma 7 4 1 1 1
 Papillary thyroid carcinoma 10 5 2 1 2
*

No significant expression.

Expressed in >66% of cell population.

Expressed in 33% to 66% of cell population.

§

Expressed in <33% of cell population.